These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New Developments in the Management of Recurrent Pericarditis. Imazio M; Mardigyan V; Andreis A; Franchin L; De Biasio M; Collini V Can J Cardiol; 2023 Aug; 39(8):1103-1110. PubMed ID: 37075863 [TBL] [Abstract][Full Text] [Related]
8. Recurrent Pericarditis: Modern Approach in 2016. Imazio M; Adler Y; Charron P Curr Cardiol Rep; 2016 Jun; 18(6):50. PubMed ID: 27108360 [TBL] [Abstract][Full Text] [Related]
9. Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis. Peiffer-Smadja N; Domont F; Saadoun D; Cacoub P Autoimmun Rev; 2019 Jun; 18(6):621-626. PubMed ID: 30959210 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy. Schwier NC; Hale GM; Davies ML Pharmacotherapy; 2017 Mar; 37(3):305-318. PubMed ID: 28079270 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Scardapane A; Brucato A; Chiarelli F; Breda L Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute and recurrent pericarditis. What the clinical cardiologist should know]. Imazio M; Trinchero R G Ital Cardiol (Rome); 2008 Dec; 9(12):826-34. PubMed ID: 19119692 [TBL] [Abstract][Full Text] [Related]
13. Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al. Brucato A; Imazio M; Spodick D; Adler Y Arthritis Rheum; 2009 Aug; 60(8):2543; author reply 2543-4. PubMed ID: 19644862 [No Abstract] [Full Text] [Related]
14. Colchicine for the prevention of recurrent pericarditis. Markel G; Imazio M; Brucato A; Adler Y Isr Med Assoc J; 2008 Jan; 10(1):69-72. PubMed ID: 18300579 [TBL] [Abstract][Full Text] [Related]
15. [Recurrent pericarditis: New treatment]. Cacoub P Rev Med Interne; 2020 Apr; 41(4):223-225. PubMed ID: 31874776 [No Abstract] [Full Text] [Related]
16. Old drugs with new uses. Colchicine for treatment of recurrent pericarditis. Adolph RJ Circulation; 1990 Oct; 82(4):1505-6. PubMed ID: 2401079 [No Abstract] [Full Text] [Related]
17. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353 [TBL] [Abstract][Full Text] [Related]
18. Recurrent pericarditis in children and adolescents: a multicentre cohort study. Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459 [TBL] [Abstract][Full Text] [Related]
19. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients. Dagan A; Langevitz P; Shoenfeld Y; Shovman O Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216 [TBL] [Abstract][Full Text] [Related]
20. Resistant or recurrent acute pericarditis: a new therapeutic opportunity? Massardier C; Dauphin C; Eschalier R; Lusson JR; Soubrier M Int J Cardiol; 2014 Dec; 177(2):e75-7. PubMed ID: 25449496 [No Abstract] [Full Text] [Related] [Next] [New Search]